Inhibition of MAO B, but not MAO A, blocks DSP-4 toxicity on central NE neurons
- 1 September 1987
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 141 (1) , 135-138
- https://doi.org/10.1016/0014-2999(87)90420-1
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neuronsEuropean Journal of Pharmacology, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- The effect of DSP-4 (N-[2-chloroethyl]-N-ethyl-2-bromobenzylamine) on monoamine oxidase activities in tissues of the ratJournal of Pharmacy and Pharmacology, 1981
- DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)—A useful denervation tool for central and peripheral noradrenaline neuronsEuropean Journal of Pharmacology, 1981
- LONG‐TERM EFFECTS OF N‐2‐CHLOROETHYL‐N‐ETHYL‐2‐BROMOBENZYLAMINE HYDROCHLORIDE ON NORADRENERGIC NEURONES IN THE RAT BRAIN AND HEARTBritish Journal of Pharmacology, 1976
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968